why choose us

First received: November 16, 2023

Clinical Trial: Polypill for Prevention of Cardiomyopathy

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Type 2 Diabetes

Study Type: INTERVENTIONAL


Official Title: Polypill Strategy for Prevention of Cardiomyopathy Among Patients With Diabetes at Risk of Heart Failure

Brief Summary: This study will investigate the utility of a polypill-based strategy for patients with type 2 diabetes mellitus and high risk of heart failure (HF), as assessed via the WATCH-DM risk score.Polypill therapy will consist of empagliflozin 12.5 mg, losartan 50 or 100 mg, and finerenone 10 mg daily.The study duration is 3 months, and participants will be randomized to either polypill therapy or usual care.The primary outcome is change in peak VO2 and adherence to usual care.The investigators hypothesize that the use of…

Read more